MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
257.73%
Quick Ratio
230.04%
Cash Ratio
123.43%
Debt to Asset Ratio
88.53%
Unit: Dollar
Assets Breakdown
    • Intangible assets, net
    • Cash and cash equivalents
    • Investment in equity securities
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total debt
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
15,421,170
16,578,857
14,939,646
16,958,744
Accounts receivable-Related Party
-
-
-
9,081
Convertible loan receivable
-
-
-
0
Accounts receivable
-
11,998,075
12,085,845
11,989,698
Accounts receivable, net
12,572,651
-
-
-
Inventory, net
3,459,921
3,948,748
3,385,956
3,511,850
Prepaid and other assets
741,733
948,620
714,115
1,200,083
Current assets related to discontinued operations (note 3)
5,203
67,863
100,117
-
Total current assets
32,200,678
33,542,163
31,225,679
33,669,456
Intangible assets, net
17,277,013
18,640,673
21,100,783
40,992,568
Goodwill
3,601,781
3,601,781
3,601,781
3,601,781
Investment in equity securities
13,730,703
14,626,858
12,588,476
10,515,812
Right of use assets operating leases
1,909,278
2,075,634
2,154,721
1,088,149
Property and equipment, net
426,934
456,962
417,208
8,899,879
Total long-term assets
36,945,709
39,401,908
39,862,969
65,098,189
Total assets
69,146,387
72,944,071
71,088,648
98,767,645
Accounts payable-Nonrelated Party
-
2,313,761
1,139,794
1,457,301
Accounts payable-Related Party
-
25,000
27,339
32,355
Accounts payable
1,401,443
-
-
-
Accrued bonuses and commissions
6,801,395
11,781,435
10,876,267
10,199,451
Accrued royalties and expenses
3,562,415
2,684,626
2,655,436
2,964,143
Earnout liabilities current
-
235,001
228,001
39,659
Operating lease liabilities current
383,153
353,229
338,990
182,935
Current liabilities related to discontinued operations (note 3)
345,585
1,233,478
2,092,142
-
Total current liabilities
12,493,991
18,626,530
17,357,969
14,875,844
Total debt
47,286,043
46,926,976
-
-
Less unamortized debt issuance costs
808,956
956,039
-
-
Earnout liabilities long-term
-
-
-
2,110,945
Long-term debt
46,477,087
45,970,937
45,089,787
44,216,662
Operating lease liabilities long-term
1,669,529
1,868,703
1,963,475
1,051,290
Other long-term liabilities
571,320
548,125
536,883
1,120,958
Total long-term liabilities
48,717,936
48,387,765
47,590,145
48,499,855
Total liabilities
61,211,927
67,014,295
64,948,114
63,375,699
Common stock 0.001 par value, 20,000,000 shares authorized 9,193,394 issued and outstanding as of june 30, 2026 and 8,946,913 issued and outstanding as of december 31, 2025
9,194
8,948
8,931
8,904
Additional paid-in capital
82,826,049
81,232,536
79,833,871
78,678,081
Accumulated deficit
-74,891,763
-75,303,042
-73,693,846
-43,287,572
Total sanara medtech shareholders equity
7,943,480
5,938,442
6,148,956
35,399,413
Equity attributable to noncontrolling interest
-9,020
-8,666
-8,422
-7,467
Total shareholders equity
7,934,460
5,929,776
6,140,534
35,391,946
Total liabilities and shareholders equity
69,146,387
72,944,071
71,088,648
98,767,645
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Intangible assets, net$17,277,013 (-57.85%↓ Y/Y)Investment in equitysecurities$13,730,703 (30.57%↑ Y/Y)Goodwill$3,601,781 (0.00%↑ Y/Y)Right of use assets operating leases$1,909,278 (75.46%↑ Y/Y)Property and equipment,net$426,934 (-95.20%↓ Y/Y)Cash and cashequivalents$15,421,170 (-9.07%↓ Y/Y)Accounts receivable, net$12,572,651 Inventory, net$3,459,921 (-1.48%↓ Y/Y)Prepaid and other assets$741,733 (-38.19%↓ Y/Y)Current assets relatedto discontinued...$5,203 Total long-termassets$36,945,709 (-43.25%↓ Y/Y)Total current assets$32,200,678 (-4.36%↓ Y/Y)Total assets$69,146,387 (-29.99%↓ Y/Y)Total liabilities andshareholders equity$69,146,387 (-29.99%↓ Y/Y)Total liabilities$61,211,927 (-3.41%↓ Y/Y)Total shareholdersequity$7,934,460 (-77.58%↓ Y/Y)Equity attributable tononcontrolling interest-$9,020 (-20.80%↓ Y/Y)Total long-termliabilities$48,717,936 (0.45%↑ Y/Y)Total currentliabilities$12,493,991 (-16.01%↓ Y/Y)Total sanara medtechshareholders equity$7,943,480 (-77.56%↓ Y/Y)Accumulated deficit-$74,891,763 (-73.01%↓ Y/Y)Long-term debt$46,477,087 (5.11%↑ Y/Y)Operating leaseliabilities long-term$1,669,529 (58.81%↑ Y/Y)Other long-termliabilities$571,320 (-49.03%↓ Y/Y)Accrued bonuses andcommissions$6,801,395 (-33.32%↓ Y/Y)Accrued royalties andexpenses$3,562,415 (20.18%↑ Y/Y)Accounts payable$1,401,443 Operating leaseliabilities current$383,153 (109.45%↑ Y/Y)Current liabilitiesrelated to discontinued...$345,585 Additional paid-in capital$82,826,049 (5.27%↑ Y/Y)Less unamortizeddebt issuance costs$808,956 Common stock 0.001 parvalue, 20,000,000...$9,194 (3.26%↑ Y/Y)Total debt$47,286,043

Sanara MedTech Inc. (SMTI)

Sanara MedTech Inc. (SMTI)